MPT: High Dose Pitavastatin OK in Asian Population

ACC Conference Reporter

AHA 2017 | ANAHEIM — Asian patients with documented coronary artery disease treated with a high dose of pitavastatin (Livalo) had reduced cardiac events in a large, randomized, open-label trial called REAL-CAD, compared to similar patients treated with a low dose of the drug, researchers said here. Read More >>>

Keywords: AHA Annual Scientific Sessions, AHA17

< Back to Listings